BridgeMD
New treatment option for Lung Cancer
Official title The Impact of AI Assistance on Radiologist Performance and Healthcare Costs in LDCT-Based Lung Cancer Screening
ClinicalTrials.gov ID: NCT06988579
What this study is testing
- What it's testing
- AI diagnostic systems show great promise for improving lung cancer screening in community healthcare settings. While not originally designed for primary care, these tools demonstrate capabilities in nodule detection and workflow optimization.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 74. Healthy volunteers may be eligible.
You may be able to join if
- Aged 45-74 years
- Permanent resident of participating study communities
- No prior history of lung cancer and no lung cancer screening within the past 3 months
- Able to comprehend and voluntarily sign informed consent, with willingness to participate in long-term follow-up
You likely can't join if
- Individuals with a confirmed diagnosis of lung cancer
- Those with severe comorbidities contraindicating CT imaging
- Inability to understand study protocols or provide informed consent due to cognitive impairment
- Concurrent participation in other clinical trials that may interfere with study outcomes
- Unable to comply with follow-up requirements
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 74 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.